↓ Skip to main content

The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and…

Overview of attention for article published in Frontiers in oncology, October 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
2 news outlets
policy
2 policy sources
twitter
5 X users

Readers on

mendeley
190 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development
Published in
Frontiers in oncology, October 2016
DOI 10.3389/fonc.2016.00215
Pubmed ID
Authors

Linda G. W. Kerkmeijer, Clifton D. Fuller, Helena M. Verkooijen, Marcel Verheij, Ananya Choudhury, Kevin J. Harrington, Chris Schultz, Arjun Sahgal, Steven J. Frank, Joel Goldwein, Kevin J. Brown, Bruce D. Minsky, Marco van Vulpen, On Behalf of the MR-Linac Consortium Clinical Steering Committee

Abstract

An international research consortium has been formed to facilitate evidence-based introduction of MR-guided radiotherapy (MR-linac) and to address how the MR-linac could be used to achieve an optimized radiation treatment approach to improve patients' survival, local, and regional tumor control and quality of life. The present paper describes the organizational structure of the clinical part of the MR-linac consortium. Furthermore, it elucidates why collaboration on this large project is necessary, and how a central data registry program will be implemented.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 190 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Finland 1 <1%
United States 1 <1%
Germany 1 <1%
Unknown 187 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 31 16%
Student > Ph. D. Student 29 15%
Student > Master 29 15%
Other 13 7%
Student > Doctoral Student 11 6%
Other 27 14%
Unknown 50 26%
Readers by discipline Count As %
Medicine and Dentistry 57 30%
Physics and Astronomy 29 15%
Engineering 8 4%
Nursing and Health Professions 7 4%
Computer Science 5 3%
Other 14 7%
Unknown 70 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2023.
All research outputs
#1,597,188
of 26,150,873 outputs
Outputs from Frontiers in oncology
#295
of 22,908 outputs
Outputs of similar age
#27,413
of 328,491 outputs
Outputs of similar age from Frontiers in oncology
#3
of 64 outputs
Altmetric has tracked 26,150,873 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 22,908 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,491 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.